Ealixir, Inc.
Ealixir, Inc. (EAXR) Financial Performance & Income Statement Overview
Review Ealixir, Inc. (EAXR) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Ealixir, Inc. (EAXR) Income Statement & Financial Overview
View the income breakdown for Ealixir, Inc. EAXR across both annual and quarterly reports.
| Metric | Q1 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|
| Revenue | $675525.00 | $1.16M | $278736.00 |
| Cost of Revenue | $675525.00 | $94775.00 | $179963.00 |
| Gross Profit | $0.00 | $1.07M | $98773.00 |
| Gross Profit Ratio | $0.00 | $0.92 | $0.35 |
| R&D Expenses | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $764823.00 | $1.02M | $848320.00 |
| Operating Expenses | $764823.00 | $1.02M | $848320.00 |
| Total Costs & Expenses | -$786516.00 | $1.02M | $1.03M |
| Interest Income | $0.00 | $0.00 | $0.00 |
| Interest Expense | $6614.00 | $6845.00 | $4191.00 |
| Depreciation & Amortization | $21693.00 | $21073.00 | $40582.00 |
| EBITDA | $426194.00 | $67250.00 | -$708965.00 |
| EBITDA Ratio | $0.63 | $0.06 | -$2.54 |
| Operating Income | -$110991.00 | $47224.00 | -$749547.00 |
| Operating Income Ratio | -$0.16 | $0.04 | -$2.69 |
| Other Income/Expenses (Net) | $637684.00 | $33882.00 | -$4191.00 |
| Income Before Tax | $526693.00 | $81106.00 | -$753738.00 |
| Income Before Tax Ratio | $0.78 | $0.07 | -$2.70 |
| Income Tax Expense | $73096.00 | $80824.00 | -$92857.00 |
| Net Income | $453597.00 | $282.00 | -$660881.00 |
| Net Income Ratio | $0.67 | $0.00 | -$2.37 |
| EPS | $0.007 | $0.00 | -$0.01 |
| Diluted EPS | $0.007 | $0.00 | -$0.01 |
| Weighted Avg Shares Outstanding | $60.28M | $60.28M | $60.28M |
| Weighted Avg Shares Outstanding (Diluted) | $60.28M | $60.28M | $60.28M |
Over the last four quarters, Ealixir, Inc. achieved steady financial progress, growing revenue from $278736.00 in Q4 2024 to $1.16M in Q2 2025. Gross profit stayed firm with margins at 92% in Q2 2025 versus 35% in Q4 2024. Operating income totaled $47224.00 in Q2 2025, maintaining a 4% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $67250.00. Net income dropped to $282.00, with EPS at $0.00. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan